
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3

Ouro Fino Saude Animal Participacoes SA
Operating Expenses
Ouro Fino Saude Animal Participacoes SA
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3
|
Operating Expenses
R$349.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Hypera SA
BOVESPA:HYPE3
|
Operating Expenses
-R$2.7B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-8%
|
Ouro Fino Saude Animal Participacoes SA
Glance View
Ouro Fino Saúde Animal Participações SA engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals. The firm manufactures veterinary products using scientific technology in the Company's laboratories. The firm's products are divided into six sectors: Wholesale, Birds, Cattle, Equine, Pet and Pigs. The Wholesale area is divided into four lines: Anti-Mastiticos, producing antibiotics killing bacteria and lumps; Antimicrobial, which focuses on the treatment of bacterial infectious diseases; Ectoparasiticides, concentrated on insect repellent products, and Endectocides, which is the treatment and control of internal and external diseases of cattle, sheep and swine parasites. There is also one additional line of products divided for additives, biological, inoculants, diagnostic kit, probiotics, silage and other supplements, among others.

See Also
What is Ouro Fino Saude Animal Participacoes SA's Operating Expenses?
Operating Expenses
349.2m
BRL
Based on the financial report for Dec 31, 2024, Ouro Fino Saude Animal Participacoes SA's Operating Expenses amounts to 349.2m BRL.